HW
Howard G. Welgus (Director) filed 10 Form 4 reports in the trailing twelve months (0 purchases, 10 sales), most often in Arcutis Biotherapeutics, Inc. (ARQT). The largest single filing was $302K of ARQT (10,000 sh × $30.21, as filed), executed Dec 1 2025. Data as of Nov 8 2026.
Add to watchlistReturn, ttmiAverage return per filing, trailing twelve months
–
no purchases on file
Delay-adjustediThe same average, entered at disclosure dates
–
returns measure stock purchases only
Filings, ttm
10
0 buys · 10 sells
Median delay
–
measured on stock purchases
Volume, ttmiDollar value disclosed in the trailing twelve months
$2.0M
shares × price, as filed
Last traded
Oct 15
Filed Oct 19
Median ADV $51.3M across their filed names
Open performance→Volume by month
Buys $0
Sells $3.7M
Shares × price, as filed · by filing month · past 24 months
Sectors filed on
Healthcare
10 filings
Sector per market data · by filing · past 12 months
Most traded names
ARQTRecent filings
ARQTSALE
Arcutis Biotherapeutics, Inc.
View filing →
$151K10,000 sh × $15.12
Exec Apr 1 2025
Filed Apr 3 2025 · 5:30 PM ET ARQTSALE Arcutis Biotherapeutics, Inc. View filing → $130K
10,000 sh × $13.00
Exec Mar 3 2025
Filed Mar 4 2025 · 5:30 PM ET ARQTSALE Arcutis Biotherapeutics, Inc. View filing → $127K
10,000 sh × $12.71
Exec Feb 3 2025
Filed Feb 4 2025 · 5:30 PM ET ARQTSALE Arcutis Biotherapeutics, Inc. View filing → $147K
10,000 sh × $14.67
Exec Jan 2 2025
Filed Jan 6 2025 · 5:30 PM ET ARQTSALE Arcutis Biotherapeutics, Inc. View filing → $125K
10,000 sh × $12.51
Exec Dec 2 2024
Filed Dec 3 2024 · 5:30 PM ET